Soft tissue Intravenous drug abuse is known to be associated with significant health problems including soft tissue infections. Our department observed a concerning increase in the level of admissions of drug users presenting with severe soft tissue infections after injecting “Legal Highs”. These findings contributed to the body of evidence which led to the introduction of a Temporary Banning Order on these agents in Scotland in April 2015. The aim of this study was to investigate the effectiveness of banning orders on reducing patients presenting with soft tissue infections associated with intravenous drug abuse.

All admissions to the Orthopaedic trauma unit with soft tissue infections over three six-month periods in 2013, 2014 and 2015 were investigated. Those associated with intravenous drug usage were identified. Cases were reviewed to assess patient demographics, co-morbidities, infection characteristics and management.

There was a three-fold increase in hospital admissions for soft tissue infections resulting from intravenous drug use between 2013 and 2014. In 2013, 9.1% of admissions were related to use of “Legal Highs”, whilst in 2014 this had increased to 68.8%. After April 2015 there was a 28% reduction in admissions of intravenous drug use related soft tissue infections with “Legal High” associated admissions reduced to 39%.

“Legal Highs” were responsible for the dramatic increase in admissions associated with soft tissue infections resulting from intravenous drug abuse seen between 2013 and 2014. Introduction of Temporary Banning Orders for “Legal Highs” in April 2015 has been instrumental in reducing these admissions.

The primary aim of this study was to identify risk factors for developing neuritis and its impact on outcome following open reduction internal fixation (ORIF) of distal humerus fractures.

Patients were identified from a prospective trauma database (1995–2010). All fractures of the distal humerus (OA-OTA Type A, B, C) managed with ORIF were included. Prospective long-term follow up was collected by telephone. Demographic data, fracture classification, intraoperative details (time to surgery, tourniquet, approach, fixation technique, nerve transposition), subsequent surgeries, presence of postoperative nerve palsy, complications and range of motion were collected. The Broberg and Morrey Elbow Score and DASH score were used as functional outcome measures.

Eighty-two patients, mean age 50(range, 13–93) were included. 16% (13/82) developed post-operative ulnar neuritis, 7% (6/82) radial neuritis and 5% (4/82) longterm nonspecific dysaesthesia. Short-term (mean 10 months, range 1–120, collected in 82 patients) and long-term (mean 6 years, range 4–18, collected in 45%, 34/75, of living patients) was completed. In patients with nerve complication: average Broberg and Morrey score was 86 (76% good/excellent), average DASH was 24.7(range, 3.3–100) and Oxford Elbow Score was 39.5(range, 18–48). Compared to: 94 (96% good/excellent), 17.7(range, 0–73.3) and 43.8(range, 17–48) in patients without. Mean pain score was 3.7 in patients with nerve complication compared to 2 without. Nerve complications were seen with increased frequency in young, male patients with high energy and Type C injuries.

Nerve complication following ORIF of distal humerus fractures is relatively common. They have detrimental impact on functional outcome. Certain groups appear to be at increased risk.